What is Eisc?
Eisc operates as a specialized provider of scientific application software, focusing on the critical intersection of lab data integration and process automation. By offering the MARRS suite, the company addresses the growing demand for automated quality assurance and seamless instrument integration within analytical environments. The firm serves a broad spectrum of sectors, including pharmaceutical, environmental, and food safety industries, where regulatory compliance and data integrity are paramount. As a woman-owned enterprise, Eisc has carved out a distinct niche by streamlining complex workflows for commercial laboratories and academic institutions, effectively reducing the operational friction associated with manual data processing and reporting.
How much funding has Eisc raised?
Eisc has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Eisc
PPP
Public-Private Partnership
What's next for Eisc?
With this late-stage capital, Eisc is poised to scale its operations and enhance its product suite to meet the evolving needs of the global scientific community. The strategic focus will likely shift toward expanding its footprint in high-growth sectors such as cannabis testing and advanced pharmaceutical research, where the requirement for robust, automated data management is intensifying. By leveraging this investment, the company aims to solidify its market position as a leader in laboratory automation, potentially exploring new integrations that further simplify compliance reporting and enhance the overall efficiency of analytical workflows. The firm's ability to maintain high data integrity standards will remain a core competitive advantage as it navigates the complexities of international regulatory landscapes.
See full Eisc company page
